Rare diseases
Investigational molecules
Locations
7550 Purple Sage, 84098-5557, United States
River 2 Renal Corp. is active in research for hepatorenal syndrome-associated acute kidney injury, with a focus on patients experiencing severe renal dysfunction in the setting of advanced liver disease. Its clinical portfolio includes evaluation of therapies aimed at improving kidney recovery and reducing dependence on renal replacement therapy.
The sponsor’s work in this area centers on outcomes tied to serum creatinine improvement and restoration of renal function in patients with severe cirrhosis-related kidney impairment.
River 2 Renal Corp. runs clinical trials in conditions such as Acute kidney injury, Cardiac function disturbance postoperative, Hepatorenal syndrome, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyGermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
